HomeNewsIndiaGerman footwear brand Von Wellx to shift production to India from China: Report

German footwear brand Von Wellx to shift production to India from China: Report

Earlier reports had suggested that many companies are looking to shift from China to India as a fallout of the COVID-19 pandemic.

May 17, 2020 / 13:55 IST
Story continues below Advertisement
Representative image
Representative image

Casa Everz Gmbh, the owner of footwear German brand Von Wellx, will be shifting its entire production to Agra from China, news agency ANI has  reported quoting state Minister for Micro, Small and Medium Enterprises (MSMEs) Uday Bahan Singh.

"We are very happy to see that investment from Casa Everz Gmbh, which will be giving employment to so many people, is coming to India from China and especially to Uttar Pradesh," Singh told the news agency.

Story continues below Advertisement

The production will happen in collaboration with latric Industries Pvt Ltd, the news agency has reported.

According to Ashish Jain, the Director and CEO of latric Industries, the collaboration has the potential to generate over 10,000 direct and indirect jobs.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show